Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medifast (MED) EPS (Basic) (2016 - 2025)

Medifast (MED) has disclosed EPS (Basic) for 16 consecutive years, with -$1.65 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EPS (Basic) fell 2457.14% year-over-year to -$1.65, compared with a TTM value of -$1.7 through Dec 2025, down 1044.44%, and an annual FY2025 reading of -$1.7, down 994.74% over the prior year.
  • EPS (Basic) was -$1.65 for Q4 2025 at Medifast, down from -$0.21 in the prior quarter.
  • Across five years, EPS (Basic) topped out at $4.0 in Q2 2021 and bottomed at -$1.65 in Q4 2025.
  • Average EPS (Basic) over 5 years is $1.72, with a median of $2.29 recorded in 2022.
  • Peak annual rise in EPS (Basic) hit 130.67% in 2025, while the deepest fall reached 2457.14% in 2025.
  • Year by year, EPS (Basic) stood at $2.93 in 2021, then dropped by 16.38% to $2.45 in 2022, then crashed by 77.55% to $0.55 in 2023, then crashed by 87.27% to $0.07 in 2024, then crashed by 2457.14% to -$1.65 in 2025.
  • Business Quant data shows EPS (Basic) for MED at -$1.65 in Q4 2025, -$0.21 in Q3 2025, and $0.23 in Q2 2025.